Unknown

Dataset Information

0

N-(4-Meth-oxy-phen-yl)-N'-(5-nitro-1,3-thia-zol-2-yl)urea.


ABSTRACT: The title compound, C(11)H(10)N(4)O(4)S, is a derivative of N-(4-meth-oxy-benz-yl)-N'-(5-nitro-1,3-thia-zol-2-yl)urea (AR-A014418), a known glycogen synthase kinase 3β (GSK-3β) inhibitor. All non-H atoms in the mol-ecule are essentially coplanar, with an r.m.s. deviation of 0.045 Å and a maximum deviation of 0.115 (2) Å for the carbonyl O atom. In the crystal structure, mol-ecules are linked via N-H⋯O hydrogen bonds into one-dimensional chains along [101].

SUBMITTER: Lough AJ 

PROVIDER: S-EPMC3008116 | biostudies-literature | 2010 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

N-(4-Meth-oxy-phen-yl)-N'-(5-nitro-1,3-thia-zol-2-yl)urea.

Lough Alan J AJ   Hicks Justin W JW   Valliant John F JF   Wilson Alan A AA   Vasdev Neil N  

Acta crystallographica. Section E, Structure reports online 20100818 Pt 9


The title compound, C(11)H(10)N(4)O(4)S, is a derivative of N-(4-meth-oxy-benz-yl)-N'-(5-nitro-1,3-thia-zol-2-yl)urea (AR-A014418), a known glycogen synthase kinase 3β (GSK-3β) inhibitor. All non-H atoms in the mol-ecule are essentially coplanar, with an r.m.s. deviation of 0.045 Å and a maximum deviation of 0.115 (2) Å for the carbonyl O atom. In the crystal structure, mol-ecules are linked via N-H⋯O hydrogen bonds into one-dimensional chains along [101]. ...[more]

Similar Datasets

| S-EPMC3588441 | biostudies-other
| S-EPMC3685117 | biostudies-literature
| S-EPMC3772451 | biostudies-literature
| S-EPMC3770393 | biostudies-literature
| S-EPMC3884424 | biostudies-literature
| S-EPMC3588517 | biostudies-other
| S-EPMC3648238 | biostudies-literature
| S-EPMC3051738 | biostudies-literature
| S-EPMC3239066 | biostudies-literature
| S-EPMC3247619 | biostudies-literature